Peters Richard

Peters Richard is listed in filings as Director at Aprea Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 1, 2026, including purchase activity. Recent filings connect the profile to Aprea Therapeutics, Inc. (APRE) and Kineta, Inc. (KA). The current snapshot covers public activity from Jun 21, 2024 to Apr 1, 2026. Reported amounts are shown as $124 to $7.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.